[PRESSWIRE] TAIPEI, Taiwan and CINCINNATI, Aug. 28, 2017 -- Lumosa Therapeutics Co., Ltd. ("Lumosa"), a Taipei-based biopharmaceutical company developing innovative therapies focused on the treatment of neurological and inflammatory disease, announced today the FDA has confirmed the 505(b)(2) regulatory pathway is appropriate for the submission of the NDA of LT1001 (Naldebain®, dinalbuphine sebacate IM injection) in the US.
Press Releases in Pharmaceuticals
[PRESSWIRE] BOCA RATON, Florida, Aug. 21, 2017 -- Caret Pharma, a subsidiary of Caret Group, today announced it has entered into an agreement with Moberg Pharma AB to acquire the assets of Fiber Choice®, a line of innovative dietary supplements containing 100% natural, prebiotic fiber.
[PRESSWIRE] DUBLIN, Aug. 18, 2017 -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced an offering by Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), of $500 million aggregate principal amount of exchangeable senior notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").
[PRESSWIRE] LONDON, August 9, 2017 -- The only conference in Europe dedicated to finding the right strategy to comply with the multitude of regulations governing the development of combination products.
[PRESSWIRE] DUBLIN, May 23, 2017 -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced that Emmy®and Tony® award-winning actress and singer, Kristin Chenoweth will kick off the "Less Red, More You" campaign today at an exclusive event in New York City.
[PRESSWIRE] BRUSSELS, May 16, 2017 -- Systech International, a global technology solutions leader for the pharmaceutical industry, is proud to announce its upcoming serialisation webinar titled "The Clock is Ticking: Overcoming the Challenges of Implementing Serialisation in the EU"on 24 May 2017.
[PRESSWIRE] Calgary, Alberta, Canada - 27 March, 2017 -- Developed by AOR, Curcumin Ultra combines superior free-form curcumin (CurQfen®) with water-soluble turmeric polysaccharides (Turmacin®) for a long lasting synergistic effect for inflammation and pain relief.
[PRESSWIRE] SYDNEY, March 6, 2017 --Australian oncology-focused biotechnology company Novogen Limited (ASX: NRT; NASDAQ: NVGN) is pleased to announce that it has been awarded a grant of up to A$3m over three years under the Cooperative Research Centre Project (CRC-P) scheme managed by the Australian Department of Industry Innovation and Science (DIIS).
[PRESSWIRE] WESTERHAM, England, January 16, 2017 -- A major investment in the leading source of drug discovery industry information - Drug Target Review - has led to a comprehensive relaunch.
[PRESSWIRE] INDIANAPOLIS, January 5, 2017 -- Eli Lilly and Company (NYSE: LLY) today announced a series of changes to its organization and leadership structure to better align them with the company's growth opportunities.